Skip to main content
. 2022 Aug 9;13:4675. doi: 10.1038/s41467-022-32363-4

Fig. 3. Cumulative incidence of Omicron infections in the BA.1-against-BA.2 and BA.2-against-BA.1 studies.

Fig. 3

Cumulative incidence of a BA.2 and b BA.1 Omicron infections in the BA.1-against-BA.2 and BA.2-against-BA.1 studies, respectively. a includes 21,145 biologically independent samples for each of the BA.1-infected and the uninfected-control cohorts. b includes 110,315 biologically independent samples for each of the BA.2-infected and the uninfected-control cohorts.